Abortion pills can be obtained &#8220;as quickly as an Amazon transaction&#8221; thanks to a massive network of foreign and domestic pill sellers that routinely flout federal law.
A <a href="https://www.scribd.com/document/1043490291/An-Overview-of-Online-Abortion-Drug-Access-in-Post-Dobbs-America-ARS-42?_gl=1*1kyfs09*_up*MQ..*_ga*MTg2MzY1OTg1Mi4xNzc5ODAwOTUy*_ga_Z4ZC50DED6*czE3Nzk4MDA5NTEkbzEkZzAkdDE3Nzk4MDA5NTEkajYwJGwwJGgw*_ga_8KZ8BV0P5W*czE3Nzk4MDA5NTEkbzEkZzAkdDE3Nzk4MDA5NTEkajYwJGwwJGgw">new study</a> from the Charlotte Lozier Institute, first shared with The Daily Wire, found the distribution of abortion pills largely “uncontrolled” and available across the country despite pro-life laws. The study noted that the majority of abortion pill sellers ignore FDA regulations and identified at least eight online pill providers that use so-called shield laws to ship pills into states where medication abortion is technically illegal. 
Researcher Mia Steupert found that an “increase in the proliferation of foreign and domestic online providers of abortion drugs&#8221; and &#8220;the enactment of shield laws all contributed to a post-Dobbs landscape where abortion drugs are readily available on all corners of the internet to women in all 50 states and D.C.”
The Charlotte Lozier Institute is the research arm of the Susan B. Anthony Pro-Life America organization. 
The release of the study comes as pro-life groups have put pressure on the Trump administration to reverse Biden-era regulations that allowed abortion pills to be sent to women without in-person doctor visits. The Supreme Court ruled earlier this month to allow mail-order abortions to continue as the FDA faces lawsuits over the removal of the in-person requirement. The FDA says it is conducting a safety review of the deadly drug. 
“The Joe Biden rule stripping away in-person doctor visits allows the online abortion drug industry to send mifepristone to kill unborn children far beyond the 10-week timeframe the FDA has established — putting women at increased risk for life-threatening complications,” SBA Pro-Life America President Marjorie Dannenfelser told The Daily Wire. 
“Anyone can get these drugs with a few taps on their phone. You don’t have to prove how far along you are, that you’re pregnant, or even that you’re a woman to obtain these drugs,” she added. 
<div id="attachment_1101657" style="width: 931px" class="wp-caption alignnone"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-1101657" class="size-full wp-image-1101657" src="https://dw-wp-production.imgix.net/2026/05/Screenshot-2026-05-22-at-12.23.33-PM.png" alt="" width="921" height="400" srcset="https://dw-wp-production.imgix.net/2026/05/Screenshot-2026-05-22-at-12.23.33-PM.png 921w, https://dw-wp-production.imgix.net/2026/05/Screenshot-2026-05-22-at-12.23.33-PM-300x130.png 300w, https://dw-wp-production.imgix.net/2026/05/Screenshot-2026-05-22-at-12.23.33-PM-768x334.png 768w" sizes=" (max-width: 921px) 100vw, 921px" />Charlotte Lozier Institute Graphic on the online world of abortion pill sellers.</div>
Shield laws have been adopted in Democrat-controlled states like New York and Massachusetts, which state officials say gives people who ship illegal abortion pills into states like Tennessee or Texas immunity from prosecution. Pro-life advocates have argued that shield laws effectively nullify states that have prohibited doctors from administering medication abortions.  
Domestic groups operating under shield laws include the Massachusetts Medication Abortion Access Project, We Take Care of Us, Aid Access, and several others, <a href="https://lozierinstitute.org/wp-content/uploads/2026/05/American-Reports-42-Appendices.pdf">according</a> to the study, which includes an appendix listing dozens of online pill sellers. 
<a href="https://www.dailywire.com/news/how-leftist-networks-flood-red-states-with-risky-abortion-pills-with-no-consequences">RELATED: How A Leftist Network Of Websites Floods Red States With Abortion Pills With No Consequences</a>
One reviewer wrote on the We Take Care of Us <a href="https://www.wetakecareof.us/">website</a> said she came from “a state where abortion is not allowed,” while another referred to getting the abortion pill, which ends the life of an unborn child, as “literally a life safer [sic].”
“There are no laws directly criminalizing the ingestion of abortion pills in any state, however there can be legal risk associated with abortion care,” the We Take Care of Us website <a href="https://www.wetakecareof.us/faqs">says</a>. 
We Take Care of Us will send women abortion pills “in advance” before they become pregnant. 
<div id="attachment_1101647" style="width: 1449px" class="wp-caption alignnone"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-1101647" class="wp-image-1101647 size-full" src="https://dw-wp-production.imgix.net/2026/05/Screenshot-2026-05-22-at-1.01.27-PM.png" alt="" width="1439" height="865" srcset="https://dw-wp-production.imgix.net/2026/05/Screenshot-2026-05-22-at-1.01.27-PM.png 1439w, https://dw-wp-production.imgix.net/2026/05/Screenshot-2026-05-22-at-1.01.27-PM-300x180.png 300w, https://dw-wp-production.imgix.net/2026/05/Screenshot-2026-05-22-at-1.01.27-PM-958x576.png 958w, https://dw-wp-production.imgix.net/2026/05/Screenshot-2026-05-22-at-1.01.27-PM-768x462.png 768w" sizes=" (max-width: 1439px) 100vw, 1439px" />We Take Care of Us.</div>
Aid Access <a href="https://aidaccess.org/en/about-us">says</a> it provides abortion pills &#8220;to people in all 50 states&#8221; and boasts it has facilitated the deaths of over 200,000 unborn babies.
Multiple foreign pill providers were also scrutinized in the study. 
“These are typically foreign websites that allow anyone to buy abortion drugs, oftentimes as quickly as an Amazon transaction,” Steupert wrote. “These e-commerce websites obtain abortion drugs from international manufacturers and then either ship the drugs directly to the customer or to a U.S. middleman who mails them around the country.”
The study identified Telefem Mexico, Abortion Pills in Private, and Women on Web as three of the organizations that sell pills to Americans. Pills purchased from <a href="https://telefem.org/en/frequent-questions/">Telefem Mexico</a> are picked up on the Mexico side of the southern border, while the other two websites purport to ship pills into the United States. 
Abortions Pills in Private is based in a business park in the United Arab Emirates that says it ships to “anywhere” in the United States. In a drop-down menu, visitors can select from a variety of states with the strongest pro-life protections, including Tennessee. 
The pill provider says that it offers “confidential, medically reviewed services that ships abortion pill kits discreetly to addresses across Tennessee.” 
Women on the Web <a href="https://www.womenonweb.org/en/order-abortion-pill-online/usa/">says</a> that it provides abortion pills “in all 50 states, supporting pregnancies up to 14 weeks.”
<div id="attachment_1101653" style="width: 1475px" class="wp-caption alignnone"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-1101653" class="wp-image-1101653 size-full" src="https://dw-wp-production.imgix.net/2026/05/Screenshot-2026-05-22-at-1.33.38-PM.png" alt="" width="1465" height="770" srcset="https://dw-wp-production.imgix.net/2026/05/Screenshot-2026-05-22-at-1.33.38-PM.png 1465w, https://dw-wp-production.imgix.net/2026/05/Screenshot-2026-05-22-at-1.33.38-PM-300x158.png 300w, https://dw-wp-production.imgix.net/2026/05/Screenshot-2026-05-22-at-1.33.38-PM-1024x538.png 1024w, https://dw-wp-production.imgix.net/2026/05/Screenshot-2026-05-22-at-1.33.38-PM-768x404.png 768w" sizes=" (max-width: 1465px) 100vw, 1465px" />Women on the Web.</div>
The pill seller describes itself as a “Canadian feminist non-profit organization” and brags that it has facilitated the deaths of more than 130,000 unborn babies. 
Of the foreign pill sellers scrutinized in the study, 18 did not require any kind of ID, and 17 shipped abortion drugs not approved by the FDA, the study found.
Even if the providers do not purport to send pills into states with pro-life protections, most appear to completely ignore FDA regulations. The study also found that 81% of online pill sellers do not follow the FDA restrictions for abortion, including that the pill be taken within ten weeks of conception. 
“Of online abortion drug sellers within the formal U.S. healthcare system that publicly report the gestational age at which they will ship abortion drugs, only 19% complied with the FDA’s requirement to not ship the drugs after 70 days’ gestation. This means 64 sellers violated the FDA’s safety limit,” Steupert wrote. 
Additionally, the majority of pill providers also do not follow the Risk Evaluation and Mitigation Strategy requirements outlined by the FDA for the abortion drug. These requirements include things like prescriber and dispenser guidelines. 
Back in 2019, the FDA sent a letter to 28 online pill sellers who were accused of violating abortion pill regulations. Steupert said that 10 of these pill sellers were still violating federal regulations despite the warning. 
“Of the 28 websites implicated in the FDA’s 2019 abuse letters, 10 are still actively breaking U.S. federal law by selling unapproved and unbranded abortion drugs they claim are FDA-approved,” she wrote.  
The report identified sites like <a href="https://www.abortionrx.com/contact.html">Abortionrx</a> and <a href="https://www.nopregnancy.com/contact.html">Nopregnancy</a> as two of the websites that were ignoring the FDA’s warnings. Both pill sellers have alleged &#8220;FDA approved&#8221; stamps on the bottom of their webpages. 
<div id="attachment_1101663" style="width: 2434px" class="wp-caption alignnone"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-1101663" class="wp-image-1101663 size-full" src="https://dw-wp-production.imgix.net/2026/05/Screenshot-2026-05-25-at-9.14.51-AM.png" alt="" width="2424" height="366" srcset="https://dw-wp-production.imgix.net/2026/05/Screenshot-2026-05-25-at-9.14.51-AM.png 2424w, https://dw-wp-production.imgix.net/2026/05/Screenshot-2026-05-25-at-9.14.51-AM-300x45.png 300w, https://dw-wp-production.imgix.net/2026/05/Screenshot-2026-05-25-at-9.14.51-AM-1024x155.png 1024w, https://dw-wp-production.imgix.net/2026/05/Screenshot-2026-05-25-at-9.14.51-AM-768x116.png 768w, https://dw-wp-production.imgix.net/2026/05/Screenshot-2026-05-25-at-9.14.51-AM-1536x232.png 1536w, https://dw-wp-production.imgix.net/2026/05/Screenshot-2026-05-25-at-9.14.51-AM-2048x309.png 2048w" sizes=" (max-width: 2424px) 100vw, 2424px" />Abortionrx.</div>
Steupert told The Daily Wire her paper should serve as a wake-up call to federal policymakers. 
“No one should be able to obtain abortion drugs as easily as purchasing something off Amazon,” she said. “The egregious findings of this paper should serve as a wake-up call to policymakers that a wild west of online abortion drug access only serves to end unborn life at all costs, even at the expense of women’s safety.”

Foetus ultrasound

Abortion Drugs Now Arrive As Fast As An Amazon Package

Ordering Abortion Drugs Is As Easy Shopping On Amazon

Abortion

Abortion drugs

Pro-Life Movement

On the world stage, President Donald Trump has long emphasized negotiating from a position of strength. He applied that same approach domestically with the creation of TrumpRx — a platform intended to give consumers, particularly those without prescription drug insurance, access to safe, effective, FDA-approved medications at reduced prices. By bringing major pharmaceutical companies to the table, Trump sought to leverage scale and pressure to deliver lower costs. The program bears his name, signaling that it is not incidental but central to his healthcare agenda.
Yet actions — or more precisely, inaction — by the previous FDA commissioner undermined that effort.
One of the fastest-growing segments of the pharmaceutical market is GLP-1 weight-loss drugs. These treatments are transforming the lives of many Americans struggling with obesity, offering not just cosmetic benefits but meaningful improvements in long-term health. Even with prices coming down, many Americans without insurance coverage — or whose plans exclude weight-loss drugs — still struggle to afford them. In that environment, TrumpRx should be a natural destination for consumers seeking affordable, legitimate options.
Some consumers have turned to it. But for many, the promise of TrumpRx is being undermined by a parallel market offering similar-looking products at even lower prices.
Why?
Because drug compounders have aggressively filled the gap, offering unapproved knock-off GLP-1 products at dramatically lower prices. These products are often marketed through polished, highly targeted advertising — frequently aimed at younger, vulnerable consumers — and are priced well below what even TrumpRx can offer. The problem, as experts report, is that many of these compounded drugs rely on questionable or unsafe active pharmaceutical ingredients (APIs), often sourced from overseas.
At best, these knock-offs are ineffective. At worst, they pose serious health risks. Attorneys general across multiple states have warned of potential harm, including severe adverse reactions requiring medical intervention.
The agency tasked with protecting consumers in this space is the U.S. Food and Drug Administration. Former FDA Commissioner Marty Makary talked a big game on this issue, declaring on social media that the FDA &#8220;will take swift action against companies mass-marketing illegal copycat drugs&#8221; and warning that &#8220;it&#8217;s a new era&#8221; of enforcement against misleading direct-to-consumer pharmaceutical advertising. The agency has issued more than 50 warning letters to telehealth firms over the past year, established a &#8220;Green List&#8221; of vetted API suppliers, and on April 30, 2026, formally proposed to exclude semaglutide, tirzepatide, and liraglutide from the 503B bulks list — a step that, if finalized, I’m told would shut the door on most large-scale compounding of these drugs.
But Makary&#8217;s pace and reach of enforcement have not yet matched the rhetoric. A parallel market for unsafe knock-offs continues to flourish in plain sight, and the gap between what the commissioner promised and what is actually happening on the ground is the problem.
Consider the FDA&#8217;s &#8220;Green List&#8221; of API suppliers. In theory, this list is meant to identify trusted sources whose products can move more easily through customs. In practice, key allies point to FOIA-released inspection records of suppliers believed to be on the list that reveal troubling deficiencies — foreign residue on equipment marked &#8220;clean,&#8221; canvas glove pieces left behind in clean rooms, rainwater in storage areas, water leaks in microbiology labs, and live and dead insects in places they should never appear. The fact that a significant portion of these suppliers are based in China — a country whose loosely regulated chemical industry is also the world&#8217;s primary source of fentanyl precursors trafficked into North America — raises additional concerns about quality control and oversight. Compounding at scale is supposed to be permitted only during shortages of approved drugs. That condition once applied to GLP-1 medications, when demand initially surged. But authorities note that the FDA resolved the tirzepatide shortage in December 2024 and the semaglutide shortage in February 2025. The legal basis for mass compounding has evaporated.
Even if the &#8220;Green List&#8221; functioned as intended — which current evidence suggests it does not — the compounding process itself introduces additional risks. The FDA has documented hundreds of adverse event reports tied to compounded GLP-1s, including dosing errors leading to hospitalization and the use of unapproved formulations such as the salt forms semaglutide sodium and semaglutide acetate, which have never been shown to be safe or effective.
Despite this, large-scale compounding continues. And there is no need for it, because safe alternatives are now widely available.
TrumpRx has secured substantial price reductions. Injectable GLP-1s that once listed at roughly $1,000 to $1,350 per month are now available on the platform at an average of about $350 — and as little as $199 for the lowest dose. Oral formulations start at $149 per month. These are meaningful gains. But their impact is undercut when compounded alternatives — often lacking the same rigorous FDA oversight, quality controls, and consistency — are available at even lower prices despite materially higher safety risks.
For seniors, obesity care is very important. In a national survey conducted by the Obesity Care Advocacy Network, 74% of medically eligible older Americans identified GLP-1 coverage as a top-tier health priority. One-third of all respondents said obesity care is a primary benchmark in evaluating whether a Medicare Part D prescription drug plan is high quality.
An outdated provision in the law establishing Medicare Part D excludes coverage of weight-loss medications. Frustrated by the pace of congressional action to repeal this restriction, President Trump has made access to legitimate, FDA-approved GLP-1s more affordable right now. The administration created a temporary Medicare GLP-1 Bridge program, effective July 1, 2026, that allows eligible Medicare beneficiaries to obtain GLP-1s with a simple $50 monthly copay.
Each consumer who chooses an unapproved compounded product over an FDA-approved drug available through TrumpRx or the Medicare Bridge represents a failure of the federal government and the program. The administration is expanding access to safe, affordable therapies, including GLP-1s, while another arm of the federal government — the FDA — was continuing to permit a sometimes lower-cost but demonstrably higher-risk parallel market to persist, one in which product variability, dosing inconsistencies, and sterility concerns can pose real dangers to patients.
TrumpRx and the Medicare Bridge for GLP-1s were designed to give Americans access to safe, effective medications at reasonable prices. Expanding access to treatments like GLP-1s has broader public health implications, including reducing the long-term costs of obesity-related conditions for programs like Medicare and Medicaid. That is a meaningful achievement.
But these programs cannot deliver on their promise if Americans continue to be drawn toward cheaper, riskier alternatives that the federal government has the authority — and the duty — to shut down. The previous FDA administrator’s regulatory gaps and inconsistent enforcement are allowing unsafe alternatives to compete directly with a program designed to provide safer ones.
President Trump was right to fire Marty Makary on this failure alone. I implore him to ensure that his next FDA administrator gets this issue right and gives TrumpRX the tools it needs to succeed.
***
Ken Blackwell is the former Ohio Treasurer and Secretary of State. He does a variety of national policy work through such organizations as the America First Policy Institute, the Family Research Council, the Public Interest Legal Foundation, and the Council for National Policy.

Still life of the new Wegovy 4mg semaglutide tablets with weight scale

How The FDA Can Trim The Fat With Makary’s Ouster

DW Opinion

glp-1

Marty Makary

Trump Rx

The resignation of FDA Commissioner Dr. Marty Makary creates an opportunity for the agency to return to its mission of protecting the public by ensuring drugs are safe. Whether Kyle Diamantas is running the agency long-term or the administration expediently appoints someone new, now is the time to address the most significant public health crisis of our time: the widespread distribution of mail-order abortion drugs.
During the COVID-19 pandemic, the Biden administration recklessly stripped away basic requirements for the abortion drug mifepristone, such as in-person doctor&#8217;s visits. The intention was to expand abortion nationwide if Roe v. Wade was overturned. This mail-order policy has pushed abortion drugs into pro-life states, violating their laws, ending lives, and endangering women and girls. And it’s still in place.
This Biden policy is the reason abortions have risen, not fallen, in the post-Dobbs era, with more than <a href="https://lozierinstitute.org/new-report-confirms-abortions-continue-to-rise-after-dobbs/">one million</a> unborn children dying annually. Even in states with strong pro-life protections, tens of thousands of abortions persist each year, driven in large part by this unchecked spread of mail-order abortion drugs. We know 90,000 abortions are occurring annually just in the states that protect life all throughout pregnancy.
Mifepristone is manufactured and distributed to kill unborn children, but it is also highly dangerous for women. In September, HHS Secretary Robert F. Kennedy, Jr. confirmed that the Biden administration <a href="https://x.com/sbaprolife/status/1963633771908874327">&#8220;twisted&#8221;</a> data on abortion drug safety and there would be a necessary review. Studies indicate that even when these drugs are given in person with oversight, as many as <a href="https://eppc.org/publication/insurance-data-reveals-one-in-ten-patients-experiences-a-serious-adverse-event/">11%</a> of women who take these drugs experience serious adverse effects, including hemorrhaging, infection, and sepsis. Peer-reviewed research further shows that roughly <a href="https://aditum.org/journals/international-journal-of-epidemiology-and-public-health-research/current-issue/1111">three-quarters</a> of emergency room visits following abortion drug use are classified as severe or critical. According to the <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020687Orig1s026lbl.pdf">FDA’s own label</a>, abortion drugs send approximately one in 25 women to the ER.
This policy shift has also created fertile ground for abuse. Without in-person screening, there is little to prevent <a href="https://www.wsj.com/opinion/mifepristone-as-a-tool-of-coercion-a00edf87">coercion</a> or forced abortions. Cases like that of <a href="https://adflegal.org/article/rosalie-markezich-story/">Rosalie Markezich</a> – whose boyfriend allegedly ordered abortion drugs online from California and pressured her to take them against her will – highlight a disturbing reality. When you peddle drugs online to anyone, vulnerable women and their children are left exposed to manipulation, violence, and irreversible harm.
Thankfully, Republican attorneys general have challenged the Biden policy, with one case brought by Louisiana rising to the top. The 5th U.S. Circuit Court of Appeals recently moved to halt the FDA’s mail-order abortion drug policy, signaling that challenges to this regulatory framework have substantial merit. The court called the Biden policy “federal interference” that nullifies Louisiana’s pro-life law and said the policy “lacked a basis in data and scientific literature.” The court said, “FDA’s own documents prove that emergency room care is statistically certain in hundreds of thousands of cases.”
Looking ahead, the path forward is clear. It is time for the FDA to return to the standard of in-person doctor visits that was in place during the first Trump administration and to fully study mifepristone. While it is my hope that mifepristone will be completely taken off the market someday, going back to basic safety standards will allow pro-life laws to take effect and add a critical layer of protection for women. Face-to-face evaluations allow for screening of ectopic pregnancies, to assess gestational age, to identify risk factors, and to detect signs of coercion.
Public opinion strongly supports this approach. <a href="https://sbaprolife.org/polling#abortion-drugs">Polling</a> consistently shows that 71% of Americans – including majorities of Independents, Democrats, and even self-identified liberals – favor reinstating in-person medical oversight for abortion drugs.
Now is the time for the FDA to do the right – and the politically smart – thing. Return to the Trump administration policy of in-person doctor visits to save lives.
***
Marjorie Dannenfelser serves as president of Susan B. Anthony Pro-Life America. She has been called “the woman who brought down Roe.”

Gender – unborn child

Makary’s Resignation Brings Renewed Hope For Banning Mail Order Abortion Drugs

Mifepristone

WASHINGTON—Embattled FDA Commissioner Marty Makary resigned Tuesday, marking a major shakeup at the health agency following a reported pressure campaign to remove him for slow walking MAHA and pro-life initiatives.
Makary ultimately called it quits over President Donald Trump&#8217;s push to authorize fruit-flavored e-cigarettes, an action he opposed, <a href="https://www.nytimes.com/2026/05/12/us/politics/trump-fires-fda-commissioner-makary.html?smtyp=cur&amp;smid=tw-nytimes">according to the New York Times</a>. But vapes may have been the last straw for Makary, who has faced growing criticism from pro-life advocates over the FDA’s handling of mifepristone and the speed of the agency’s review of the abortion drug’s safety. The U.S. Supreme Court is currently weighing whether to allow restrictions on mail-order access to the abortion drug. 
President Trump, speaking to reporters before departing for China, declined to say whether he had resigned or been fired.
&#8220;Everybody wants that job. It&#8217;s a very important job, Marty is a terrific guy,&#8221; Trump said. &#8220;He was having some difficulties; he&#8217;s a great doctor, and he was having some difficulties. But he&#8217;s going to go on, and he&#8217;s going to do well.&#8221;
<blockquote class="twitter-tweet" data-media-max-width="560">
JUST IN: President Trump responds to Dr. Marty Makary resigning from his post as FDA Commissioner:
&#8220;Everybody wants that job. It&#8217;s a very important job&#8230; He was having some difficulties, he&#8217;s a great doctor and he was having some difficulties. But he&#8217;s going to go on and he&#8217;s… <a href="https://t.co/SHG3eUyE81">pic.twitter.com/SHG3eUyE81</a>
— Fox News (@FoxNews) <a href="https://twitter.com/FoxNews/status/2054264654864548284?ref_src=twsrc%5Etfw">May 12, 2026</a></blockquote>
Senator Josh Hawley (R-MO) celebrated Makary’s resignation, calling him “uniquely destructive to the pro-life movement.
“He attempted to place pro-abortion lawyers in key positions. He slow-walked a vitally necessary review of the abortion drug mifepristone,” <a href="https://x.com/HawleyMO/status/2054249500680806518?s=20">Hawley said.</a> “He used his discretion to approve a new abortion drug when the data shows it sends 1 in 10 women to the emergency room. He froze out pro-life leaders and repeatedly stonewalled Congress. His resignation is an opportunity for the FDA to reset.” 
FDA Deputy ‌Commissioner ⁠Kyle Diamantas will lead the agency in an acting capacity, <a href="https://www.politico.com/news/2026/05/12/makary-fda-resign-white-house-00916014">according to Politico. </a>
Makary&#8217;s resignation comes after several media outlets reported that President Trump signed off on a plan to fire Makary amid agency turmoil and backlash from anti-abortion advocates. His departure follows months of mounting criticism from Democrats over vaccine policy and from pro-life advocates frustrated with the agency’s handling of mifepristone regulations.
Makary had defended the FDA’s approach, <a href="https://www.dailywire.com/news/exclusive-fda-commissioner-marty-makary-says-hes-taking-politics-out-of-science">telling The Daily Wire</a> the agency was conducting a detailed safety review of the abortion drug and that any next steps would be guided by that study.
&#8220;We have brought back gold standard science and taken politics out of the process,” Makary told The Daily Wire in an exclusive interview last week. “We’ve been going hard on what’s right. Be it the COVID vaccine, be it getting back to basic science — gold-standard science … We are going up against Big Food, Big Pharma, and we aren’t afraid to stand up to them.”
SBA Pro-Life America led the charge, calling for the termination of Makary.
“Indifference is completely unacceptable to millions of pro-life voters expecting the administration to act to save lives. Abortions are up, not down, after Dobbs, with at least 1.1 million deaths a year,” <a href="https://sbaprolife.org/newsroom/press-releases/sba-pro-life-america-intensifies-call-to-fire-makary">the group said in a statement</a>. 
“This is a five-alarm crisis for the pro-life movement and for the GOP,” the group added. “The GOP cannot win without its base and simply will not get the enthusiasm that drives turnout without leadership from the top.”
Conservative commentator Katie Pavlich said she was “sad” to see Makary leave the FDA. 
“He is a good man and was a desperately need[ed]  voice of logic, reason, courage and ethics during COVID panic. He never caved to mandate pressure, even putting his job on the line at Johns Hopkins,” <a href="https://x.com/KatiePavlich/status/2054253971951251703?s=20">she said on social media</a>.
Makary, <a href="https://www.fda.gov/about-fda/fda-organization/martin-makary">a longtime surgeon at Johns Hopkins Hospital</a> and outspoken critic of the politicization of medicine during the COVID era, is the latest official to exit the Trump administration. Since January, former Homeland Security Secretary Kristi Noem, former Attorney General Pam Bondi, and former Labor Secretary Lori Chavez-DeRemer have left their roles.
Drew Berkemeyer contributed to this report.

Press Secretary Karoline Leavitt And Cabinet Officials Hold White House Media Briefing

Embattled FDA Chief Marty Makary Resigns Amid Mounting Criticism

News

Food and Drug Administration Commissioner Martin Makary says his agency is working hard to bring back &#8220;gold standard science&#8221; while Americans&#8217; trust in science and medicine is at historic lows.
&#8220;We have brought back gold standard science and taken politics out of the process,&#8221; Makary told The Daily Wire during an exclusive interview this week. &#8220;We&#8217;ve been going hard on what&#8217;s right. Be it the COVID vaccine, be it getting back to basic science — gold-standard science &#8230; We are going up against Big Food, Big Pharma, and we aren&#8217;t afraid to stand up to them.&#8221;
Makary has drawn criticism from both sides of the aisle during his 14 months as FDA Commissioner. <a href="https://democrats-energycommerce.house.gov/media/press-releases/ec-democrats-demand-answers-fdas-covid-vaccine-memo" target="_blank" rel="noopener">Democrats</a> have criticized his vaccine policies, while pro-life groups have called for his resignation over what they say is inaction on Biden-era abortion pill regulations. Asked about safety concerns surrounding the abortion drug mifepristone, Makary told The Daily Wire the FDA is committed to addressing these concerns and that a study on the drug&#8217;s safety is underway.
&#8220;There needs to be a good, detailed granular study for mifepristone, which to date has not been done. We have committed to conducting a granular study,&#8221; Makary told The Daily Wire. &#8220;We&#8217;re doing it the right way, and that study will inform any potential next steps.&#8221;
But <a href="https://www.fda.gov/about-fda/fda-organization/martin-makary" target="_blank" rel="noopener">Makary</a> has experience swimming through the turbulent waters of public opinion. A pioneering surgeon at Johns Hopkins University, Makary is the author of more than 300 peer-reviewed medical journal articles and was one of the few scientists calling out the politicization of science during the COVID pandemic.
Under Makary, the FDA is on a mission to make American children healthier, find new treatments for diseases, and regain America&#8217;s place as a world leader in scientific breakthroughs.
&#8220;When I came into office 14 months ago, the year prior, China was doing four times the number of phase one trials as the United States,&#8221; Makary said. &#8220;In the first Trump administration, the U.S. was the leader, and that changed under the Biden administration. We walked into a mess.&#8221;
Makary says the agency is achieving its mission in record time. Within weeks of his March 2025 Senate confirmation, the FDA and the Department of Health and Human Services announced an initiative to phase out petroleum-based food dyes, something Makary says the FDA talked about doing for decades.
&#8220;We announced action to remove all nine artificial dyes from the U.S. food supply,&#8221; Makary told The Daily Wire. &#8220;A lot of companies are ahead of schedule. It is a tremendous success. These are petroleum-based artificial dyes. American kids don&#8217;t need more petroleum in their bodies.&#8221;
In the past 14 months, the FDA has also taken steps to <a href="https://www.hhs.gov/press-room/wtas-fda-announces-major-steps-implement-real-time-clinical-trials.html" target="_blank" rel="noopener">modernize</a> and increase the efficiency of drug applications and trials. The FDA launched the Commissioner&#8217;s National Priority Voucher program, which <a href="https://www.youtube.com/watch?v=CzMG6_hOB5w" target="_blank" rel="noopener">reduces wait times</a> for drug applications and allows therapies for rare diseases to forgo randomized trials, which are <a href="https://www.hhs.gov/press-room/wtas-fda-launches-framework-accelerating-therapies-ultra-rare-diseases.html" target="_blank" rel="noopener">difficult</a> to conduct due to small patient populations.
&#8220;We introduced a new pathway to approve drugs at the speed patients would demand if they&#8217;re suffering from a terminal or debilitating condition,&#8221; Makary said. &#8220;Typically, the FDA takes a year to review and file a drug application. We have that down now to one to two months, regularly.&#8221;
The Daily Wire asked Makary about criticisms he&#8217;s faced over the FDA&#8217;s rejection of several drug applications, including those for cancer treatments. Patient groups say Makary&#8217;s FDA is <a href="https://www.wsj.com/opinion/president-trumps-marty-makary-problem-08ebd71a">slow-walking</a> rare disease drugs, making companies jump through unnecessary hoops in order to get approval for things like Huntington&#8217;s Disease.
But Makary says it&#8217;s simply a matter of good science.
&#8220;There&#8217;s a very simple system at the FDA: if the drug works, it gets approved,&#8221; Makary told The Daily Wire.
In an effort to regain the public trust in science and medicine, the FDA is giving the public unprecedented transparency of the drug application process.
&#8220;If the drug fails in its trial and the FDA does not approve it, in my opinion, the public deserves to know why. So we have taken the bold step of making our decision letters public information.&#8221;
The FDA has posted the complete response letters of approved and non-approved new drug applications on its<a href="https://open.fda.gov/apis/transparency/completeresponseletters/" target="_blank" rel="noopener"> website</a>.
&#8220;In the past, politics has resulted in overruling scientists at the agency. But in this Trump administration, we stand by our scientists,&#8221; Makary told The Daily Wire.
&#8220;Every time the commissioner has overruled scientists at the FDA, it&#8217;s been a fiasco. The Biden administration overruled scientists who recommended against approving the Covid vaccine for healthy children. It was a fiasco.&#8221;
The FDA is also taking bold steps to improve the quality of school lunches and baby formula.
After hearing from parents wanting better quality food in schools, the FDA launched a <a href="https://x.com/DrMakaryFDA/status/2045249715642495124?s=20" target="_blank" rel="noopener">pilot</a> program giving schools resources to provide healthier meals to students. The program has been hugely successful, showing a 70 to 80% reduction in pesticides and 80% to 90% reduction in heavy metals contained in school lunches, Makary told The Daily Wire.
&#8220;We proved that you can make a switch to healthier food in an affordable way,&#8221; Makary said.
On April 29, the FDA released results of the <a href="https://www.fda.gov/news-events/press-announcements/fda-releases-results-largest-ever-testing-infant-formula-us" target="_blank" rel="noopener">largest-ever testing</a> of infant formula in the United States, testing more than 300 infant formula samples for contaminants such as mercury, lead, and forever chemicals like PFAS. The testing found the samples overwhelmingly had undetectable or very low levels of contaminants, which Makary called a &#8220;resounding success.&#8221;
&#8220;Many companies find it too hard to bring new products to market because you have to follow a rigid recipe,&#8221; Makary said. &#8220;So we are modernizing the monograph that&#8217;ll enable more companies to come to market, that will both lower prices and create more options for moms that are healthier, while at the same time, make the supply chain more resilient.&#8221;
In the midst of swirling public opinion, Makary remains focused on the FDA&#8217;s mission to promote strong science and healthier Americans.
&#8220;We set the priority of the agency to a simple mission of more cures, meaningful treatments, and healthier food for children.&#8221;

Untitled design – 2026-05-08T091712.133

EXCLUSIVE: FDA Commissioner Marty Makary Says He’s Taking Politics Out Of Science

Abortion Drug

MAHA

Trump Administration

Most Americans, including Democrats and independents, want to change a federal government policy allowing abortion pills to be mailed with impunity throughout the United States, according to polling obtained by The Daily Wire. 
Over two-thirds (67%) of Americans surveyed said they would support the Food and Drug Administration (FDA) reinstating an in-person doctor visit requirement for accessing an abortion pill via the mail, polling for the 85 Fund conducted by CRC Research showed. That included 72% of Republicans, 68% of independents, and 63% of Democrats. About 27% of Americans opposed reinstating the in-person requirement. 
Pro-life leaders, who have blamed the <a href="https://www.dailywire.com/news/despite-dobbs-more-babies-are-still-being-aborted-in-the-united-states">increasing abortion rates</a> across the country on mail-order abortions, touted the polling as a reason for the FDA to revoke the Biden-era policy allowing pills to be shipped without a doctor’s visit. 
“It&#8217;s overwhelmingly clear that Americans support reinstating the in-person dispensing requirement to protect women taking mifepristone,” Christina Francis, the CEO of the American Association of Pro-Life OBGYNs, told The Daily Wire. “As physicians caring for women and babies every day, we see the devastating impact that the FDA&#8217;s relaxed standards are having on women&#8217;s health and safety.” 
<div id="attachment_1065227" style="width: 1335px" class="wp-caption alignnone"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-1065227" class="size-full wp-image-1065227" src="https://dw-wp-production.imgix.net/2026/03/Screenshot-2026-03-24-at-10.27.46-AM.png" alt="" width="1325" height="740" srcset="https://dw-wp-production.imgix.net/2026/03/Screenshot-2026-03-24-at-10.27.46-AM.png 1325w, https://dw-wp-production.imgix.net/2026/03/Screenshot-2026-03-24-at-10.27.46-AM-300x168.png 300w, https://dw-wp-production.imgix.net/2026/03/Screenshot-2026-03-24-at-10.27.46-AM-1024x572.png 1024w, https://dw-wp-production.imgix.net/2026/03/Screenshot-2026-03-24-at-10.27.46-AM-768x429.png 768w" sizes=" (max-width: 1325px) 100vw, 1325px" />CRC Research.</div>
The polling was conducted from March 12-18 and sampled 1600 likely voters randomly selected from opt-in panel participants. Those surveyed were 33% Republican, 34% independent, and 32% of Democrats, with 31% identifying as pro-life, 39% as pro-choice, and 27% as somewhere in between.
Seventy percent of those surveyed also said they would support the FDA making an in-person medical evaluation required before and after taking an abortion pill, while 62% said they were more likely to support an in-person requirement after learning that some men were coercing women into having abortions. Nearly half of Americans (49%) said they would be less likely to support their representative if they supported abortion pills being shipped without a medical evaluation. 
<div id="attachment_1065241" style="width: 1357px" class="wp-caption alignnone"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-1065241" class="size-full wp-image-1065241" src="https://dw-wp-production.imgix.net/2026/03/Screenshot-2026-03-24-at-12.05.43-PM.png" alt="" width="1347" height="757" srcset="https://dw-wp-production.imgix.net/2026/03/Screenshot-2026-03-24-at-12.05.43-PM.png 1347w, https://dw-wp-production.imgix.net/2026/03/Screenshot-2026-03-24-at-12.05.43-PM-300x169.png 300w, https://dw-wp-production.imgix.net/2026/03/Screenshot-2026-03-24-at-12.05.43-PM-1024x576.png 1024w, https://dw-wp-production.imgix.net/2026/03/Screenshot-2026-03-24-at-12.05.43-PM-768x432.png 768w" sizes=" (max-width: 1347px) 100vw, 1347px" />CRC Research.</div>
The Trump administration has promised to conduct a safety study of the abortion drug, but pro-life advocates have grown impatient. They say the allowance of mail-order abortion pills allows women and leftist activists to ship pills into states where medication abortion is technically illegal. The FDA has said that reimposing the in-person requirement would interfere with the ongoing safety study. 
A Georgia woman was recently charged after investigators said she took eight abortion pills before her baby was delivered alive and survived for about an hour. &#8220;I know my infant is suffering, because I am the one who did the abortion. I want her to die,&#8221; the woman allegedly told nurses at the hospital.
Tens of thousands of abortions have been carried out in states like Texas and Tennessee with pills shipped in by activists and abortion doctors. Pro-life groups say the FDA policy allowing pills to be shipped without the in-person requirement effectively nullifies state laws.
States like Louisiana <a href="https://www.dailywire.com/news/blatantly-unlawful-red-state-challenges-fda-over-mail-order-abortions">have sued</a> the FDA to reverse the mail-order regulations. That lawsuit was joined by a woman named Rosalie Markezich, a woman who says her ex-boyfriend ordered illegal abortion pills from California and then coerced her to take them to end the life of her unborn child.
“Voters could not be speaking any more clearly on abortion drugs flooding the mail, driving up abortion rates and undermining protections for women and children,” Susan B. Anthony Pro-Life America President Marjorie Dannenfelser told The Daily Wire. “They recognize this is an urgent public health and safety crisis that demands a return to common sense, like in-person doctor visits that were required under the first Trump administration.” 
Previous polling has found similar results, including one from Cygnal that found large majorities of Republican primary voters said they would be less enthusiastic to vote in the midterm elections if GOP leaders shy away from pro-life policies
&#8220;A broad consensus exists around the dangers of mail-order abortion drugs and the risks they pose to women’s health and safety,” said David Bereit, the executive director of the Life Leadership Conference. “A majority of Americans, across the political spectrum, express serious concern that eliminating in-person medical oversight increases the likelihood of complications, coercion, and undetected abuse.”

High angle shot of Asian pregnant woman holding an ultrasound scan photo in front of her baby bump, sitting on bed at home. Mother-to-be. Precious moment in life. Preparation for a new family member. Expecting a new life. Baby and new life concept

Push Builds To Reverse Biden-Era Abortion Pill Rule

Most Americans Want Trump Admin To Reverse Course On Abortion Pill

When the Supreme Court finally overturned Roe v. Wade — reversing the worst Supreme Court decision since Dred Scott — pro-life Americans rejoiced. Little did we know the fight was only just beginning. Since then, abortion advocates have dumped millions of dollars in dark money into our states to overturn state laws, and in some cases, state constitutional provisions, protecting life. They’ve relentlessly pushed for pro-abortion judges for state courts and the federal judiciary. But above all, they’ve turned to a drug called mifepristone to bring abortion on demand to every state in the union. If pro-lifers want to protect the innocent unborn, and the health and safety of women, there’s only one thing to do: ban the chemical abortion drug.
Mifepristone first came to market in the United States in 2000, courtesy of the Clinton administration. From the beginning, it was mired in controversy. The drug was a copycat of the infamous French RU-486, which works by essentially inducing a miscarriage. This isn’t contraception. It’s not the morning-after pill. It’s a full-on abortion: the drug’s purpose is to destroy a viable pregnancy.
It was controversial because the drug carries so many side effects. It doesn’t merely kill the baby. It can also cause internal hemorrhaging, infections, sepsis, and other life-threatening conditions in the mother.
The pharma company that introduced it in the United States knew that, and took unusual and extreme measures to protect itself from liability. The name of the company is Danco. It was incorporated in the Cayman Islands. Its board of directors is secret; its investors are secret. Its corporate structure is largely shielded from public view. We do know early backers included George Soros — surprise, surprise — and other far-left activists who loudly backed population control. Their goal was simple: to put a Planned Parenthood in every mailbox in America, by developing a drug that could be shipped anywhere and cause an abortion anytime.
The Clinton administration was also aware of mifepristone’s dangers, and its FDA approval came with significant restrictions. The drug had to be prescribed by a physician. That physician had to see the patient before prescribing it, dispense the drug in person, and conduct a follow-up assessment. The FDA was also required to keep track of major health events associated with the drug and report them. The agency even slapped a “black box” warning on mifepristone’s label, meant to alert women that the drug came with serious risks.
Over time, however, one liberal administration after another removed these safeguards. 
The Obama administration dropped many of the reporting requirements and allowed non-physicians to prescribe the drug. Obama’s FDA also discarded the required follow-up visit. 
The Biden administration went further and eliminated the in-person dispensing requirement altogether.
The result? Today, mifepristone can be ordered over the internet from anywhere in the world — many of the most trafficked websites are in India — and mailed to any address in the United States. No meaningful safety protocols remain to protect women’s health or even police the integrity of the drug itself.
And what you might have expected to happen has happened. The largest study of mifepristone ever conducted found that in nearly 11% of cases, women who take the drug experience a “serious adverse health event” such as sepsis or hemorrhaging. That’s more than one in ten women. Incredibly, this rate is 22 times higher than what drug maker Danco admits to on its label.
Mifepristone’s ubiquity has also led to other horrors. Women across this country have been pressured into taking it by pro-abortion groups like Planned Parenthood, who routinely lie about the effects. And abusive partners — able to order the drug with a simple click — have intimidated or coerced women into taking it and killing babies they wanted to keep.
But of course, Danco doesn’t care: it’s making billions. Business is so lucrative, in fact, that mifepristone is the only drug the company makes. One recent piece of public reporting suggested investors’ returns top 450% — even as one in ten women who take the drug face health devastation. What has Danco done to compensate them? Nothing. They’re too busy raking in the cash.
And the far-left abortion crazies who funded Danco and worked for years to eliminate every last safety restriction, have gotten what they wanted, too. Mifepristone now accounts for 70% of abortions in the United States — a proportion that goes up every year. It is truly abortion on demand. And no matter what voters in the states decide, the number of abortions continues to grow: the drug is available by mail anywhere, irrespective of state laws.
Those harmed are women. And the innocent unborn. At least 7.5 million women have taken mifepristone since the year 2000. That means hundreds of thousands of women are sent to emergency rooms or left to cope with life-threatening conditions on their own. And millions of babies lost.
It is time for Congress to act. The last twenty years have made abundantly clear that this drug is inherently dangerous. And inherently prone to abuse. There is a direct solution: Congress should ban mifepristone for use in abortion. And Congress should give every woman harmed by the drug — and we’re talking thousands upon thousands of women — the right to sue Danco and the other drug makers who have lied to them.
Banning mifepristone in abortions is the only realistic way to end this epidemic. The FDA could theoretically reinstate some or all of the older safety restrictions, but as one recent study showed, even with safety restrictions in place, the drug still sends approximately 10% of women to the hospital with serious side effects. And it’s lethal to the baby nearly 100% of the time. Then, too, a future FDA under a liberal president could just take the safety protocols away again.
The real solution is for Congress to act, to permanently stop the drug trade in abortion by barring mifepristone from use in abortions. And to give women their voice back by finally giving them rights against the pharma kingpins.
This is not a sidelight to the fight for life. This is the fight for life. It is the fight of our time. And it cannot wait a day longer.
* * *
U.S. Senator Josh Hawley represents the state of Missouri and serves on the Senate Committees on the Judiciary; Homeland Security and Governmental Affairs; Health, Education, Labor and Pensions; and Small Business and Entrepreneurship.
The views expressed in this piece are those of the author and do not necessarily represent those of The Daily Wire.

In new motherhood, fetal health monitoring through regular ultrasounds and check-ups enables constant monitoring of the fetus’s growth and development.

The Abortion Industry Simply Changed Tactics. Now Congress Must Act.

Time To Ban The Chemical Abortion Drug

Congress

Josh Hawley

U.S. Senate

Urging Congress to take action against the abortion drug mifepristone, a woman named Elizabeth Gillete spoke out Wednesday about her horrific experience with the fatal pill.
Speaking at a press conference organized by Senator Josh Hawley (R-MO), Gillette gave her story of how the abortion drug had harmed her when she was in her 20s and ended the life of her unborn baby. After pressure from her boyfriend, she said she took an abortion pill and said when the baby was expelled from her body he had recognizable eyes, limbs, and earbuds.
“That was so different from the double period and the extra clotting that they told me that I would experience,” she said. “And in that moment, I had to decide if I was going to throw my child in the trash or flush my child down the toilet, and I chose to flush him into a septic tank.”
She said the whole experience gave her post-traumatic stress disorder.
&#8220;And instead of relief, I got horrible nightmares that started, where I would see people dying and people being murdered,&#8221; she said. &#8220;I would hear infants crying in the trash cans when I walked by them, I would hear infants crying in the toilet. I was diagnosed with post-traumatic stress disorder, which I still suffer from this day.&#8221;
Her comments came as Hawley announced Wednesday that he had introduced a bill that would ban the use of mifepristone for abortion nationwide. He said the bill was inspired by how the abortion rate has increased despite the overturning of Roe v. Wade. 
“There are more abortions now in the United States than there were when Roe was still the law of the land,” Hawley said. “It is time for Congress to ban the use of mifepristone for abortion.”
“Only Congress can address this situation. Only Congress is placed to regulate the flow of interstate drugs,” he added. 
The proposal would also allow women who were harmed by the abortion drug to sue the manufacturers for damages. 
A companion bill was introduced by Tennessee Republican Diana Harshbarger in the House. 
Mifepristone has quickly become the most common method for ending the life of an unborn baby. The fatal drug, which ends a baby’s life by cutting it off from nutrients needed to survive, has largely fueled the nationwide increase in abortion. Abortionists and leftist activists, protected by so-called shield-laws, have shipped the drug through the mail bypassing red state laws banning medication abortions. 
Data released in December by the pro-abortion Society of Family Planning <a href="https://societyfp.org/research/wecount/wecount-june-2025-data/">revealed</a> that the number of monthly abortions continued to increase in 2025 from 2024, which was itself an increase from 2023. 
Pro-life advocates including Hawley have called for the Trump administration to repeal Biden-era regulations that allowed the drug to be shipped through the mail without an in-person doctor&#8217;s visit. 
The Food and Drug Administration has said that it is conducting a safety study of mifepristone and has kept Biden-era regulations in place that allow the fatal drug to be sent through the mail with no in-person doctor visits. 
Last month, Hawley <a href="https://www.dailywire.com/news/serious-crisis-hawley-says-congress-must-act-to-combat-rising-abortion-rates?author=Leif+Le+Mahieu&amp;category=News&amp;elementPosition=undefined&amp;row=0&amp;rowType=Vertical+List&amp;title=‘Serious+Crisis’%3A+Hawley+Says+Congress+Must+Act+To+Combat+Rising+Abortion+Rates">told The Daily Wire</a> that he thought it was time for Congress to get involved in the abortion fight. 
“I think Congress needs to be involved. Congress shouldn’t be a spectator and just outsource this to other people. I think it’s time for Congress to get involved,” he said. 
Those comments came after he attended a close-door briefing with FDA Administrator Marty Makary to discuss the regulation of mifepristone. He said he thought the safety study was a “dead end.”

MixCollage-11-Mar-2026-02-45-PM-5636

She Took The Abortion Pill — What Happened Next Is Changing The Fight Over It

MixCollage-10-Feb-2026-12-00-PM-2945

Inside The Seedy World Of ‘Homebrew’ Transgender Treatments

Cryptocurrency

Drug Enforcement Agency

Transgender

The Justice Department moved Friday to block a lawsuit from Missouri challenging the Food and Drug Administration (FDA) for allowing the abortion drug mifepristone to be shipped through the mail. 
A <a href="https://storage.courtlistener.com/recap/gov.uscourts.moed.224112/gov.uscourts.moed.224112.293.1.pdf">filing</a> from the DOJ argued that allowing the suit to move forward would inhibit a safety study on the abortion pill being conducted by the Trump administration. Missouri and several other Republican-led states have asked a judge to block a COVID-era policy that relaxed regulations for dispensing the abortion pill. 
“Missouri, Kansas, and Idaho are not the only plaintiffs to have challenged the current conditions of use for mifepristone,” the Justice Department wrote. “Given this widespread debate over the safety of mifepristone, FDA has concluded that the best path forward is for the agency to undertake its review based on all the evidence before the agency.”
The filing asked the judge to put the lawsuit on hold while the FDA reviews the Risk Evaluation and Mitigation Strategy (REMS) for mifepristone or dismiss the case altogether. It comes as pro-life <a href="https://www.dailywire.com/news/republican-voters-want-action-on-mail-order-abortion-pill-as-midterms-loom?author=Leif+Le+Mahieu&amp;category=News&amp;elementPosition=undefined&amp;row=0&amp;rowType=Vertical+List&amp;title=Republican+Voters+Want+Action+On+Mail-Order+Abortion+Pill+As+Midterms+Loom">advocates</a> and <a href="https://www.dailywire.com/news/serious-crisis-hawley-says-congress-must-act-to-combat-rising-abortion-rates?author=Leif+Le+Mahieu&amp;category=News&amp;elementPosition=undefined&amp;row=0&amp;rowType=Vertical+List&amp;title=%E2%80%98Serious+Crisis%E2%80%99%3A+Hawley+Says+Congress+Must+Act+To+Combat+Rising+Abortion+Rates">lawmakers</a> have called for the Trump administration to crack down on mail-order abortion pills. 
Last year, FDA Administrator Marty Makary and Health and Human Services Director Robert F. Kennedy Jr. said that they initiated the REMS review. The study has yet to be released, and pro-life lawmakers and advocates have grown impatient as abortions continue to increase in states where medication abortion is banned due to an influx of outside pills. 
A spokesman for the Justice Department told The Daily Wire that the intent of the filing was to allow the FDA to oversee drug policy, not the federal court system. 
“In this filing, the Department of Justice requested more time from the court for the FDA to complete its review of mifepristone REMS,” the spokesman said. “As the Supreme Court recognized in a unanimous ruling less than two years ago, it is the role of the FDA – not the federal courts – to evaluate drug safety data and impose appropriate precautions.”
The filing from the DOJ dismisses concerns from pro-life states that FDA policies allow abortionists to ship pills into their states. The department said that states “remain free to make and enforce their pro-life policies” and that the federal government is not “standing in the way of Intervenor Plaintiffs enforcing their abortion laws against out-of-state prescribers of mifepristone.”
The filing <a href="https://www.dailywire.com/news/fda-claims-mail-order-abortion-policies-are-not-preventing-states-from-protecting-the-unborn">mirrors another</a> one from January, where the DOJ asked a judge not to grant a request from Louisiana also seeking to block the FDA&#8217;s abortion pill mailing policy.
Data <a href="https://www.dailywire.com/news/despite-dobbs-more-babies-are-still-being-aborted-in-the-united-states">indicate</a> that tens of thousands of abortions are still happening in states like Texas, where medication abortion is banned. While Attorney General Ken Paxton has attempted to penalize abortionists accused of shipping pills into the state, New York has so far refused to cooperate due to shield laws put in place for abortionists. 
The Friday filing was condemned by Susan B. Anthony Pro-Life America President Marjorie Dannenfelser, who has been a vocal critic of the Trump administration’s handling of medication abortion. 
“The pro-life movement has very simple demands,” she said. “There should be no place on the market for drugs meant to poison and kill innocent human beings – but at the very least, this administration can and should take them out of the mail. This is no more or less than the policy of the first Trump administration.”
The Justice Department spokesman told The Daily Wire the department remains “committed to advancing President Trump’s pro-life agenda, including through dismissing criminal prosecutions and civil lawsuits against peaceful pro-life advocates targeted by the previous administration, and using the FACE Act to protect pro-life pregnancy centers.”

President Trump Signs Order Establishing White House Great American Recovery Initiative

DOJ Makes New Move In Court Fight Over Abortion Pill

Justice Department Moves To Block Red State Lawsuit Over Abortion Pill

Department of Justice

Marjorie Dannenfelser serves as president of Susan B. Anthony Pro-Life America. She has been called “the woman who brought down Roe.”
 * * * 
Late last Friday, President Donald Trump’s Department of Justice asked a judge to dismiss Missouri v. FDA, a case brought by pro-life states over FDA rules that allow abortion drugs to be prescribed online, without doctors ever seeing or speaking to the actual patient. These rules risk women’s health, enable <a href="https://sbaprolife.org/latest-news/abortion-drugs-fuel-abuse-the-women-poisoned-against-their-will">abuse and coercion</a>, and effectively nullify all pro-life laws at the state level. In this lawsuit – it’s not the only one – the Trump DOJ argues that the policy should stand indefinitely until the FDA decides what, if anything, it will do.
The vast majority of Americans think women should be required to see a doctor before taking abortion drugs. In every poll where it’s been asked, this has been by a wide margin – including large majorities of independents, suburban women, and Gen Z, as well as nearly half of those who call themselves pro-choice. These requirements were standard for years, until, citing COVID, the Biden administration effectively removed them a few months into his term.
That Biden-era policy still stands today. As a result, throughout the country, abortion is de facto regulated by activist groups in the states with the most lax laws, who ship drugs nationally, regardless of the laws in the state where the patient lives. Many of these groups will prescribe to anyone who fills out an online form, without even requiring a video or phone call. Some advertise that they’ll send these drugs “in advance” to women who aren’t even pregnant.
These groups have no idea of the woman’s medical situation, or the actual age of the baby, creating serious health risks for the mother. Nor do they have any real confirmation of who filled out the form in the first place. Stories of abusive husbands and boyfriends obtaining these pills and forcing them on their unwilling partners have become sadly commonplace. Most recently, a baby girl in Texas named <a href="https://x.com/marjoriesba/status/2027079983009534202?s=20">Presley Mae</a> was delivered stillborn after her father slipped the drugs to her unwilling mother in secret.
Abortion drugs, to be clear, are not like “Plan B” or the “morning-after pill.” They are designed to abort unborn children much, much later. While the FDA’s own limit for the drugs is 10 weeks, the groups who send these pills often say they will provide them through the third month of pregnancy. Some emphasize – for “informational purposes” – that the pills continue to be “effective” until the fifth or sixth month, at which point the baby might survive a usual dosage. After 18 weeks, <a href="https://www.ineedana.com/pills-after-12-weeks">one group</a> warns women that they may see “spontaneous gasping or movements” from the baby, but notes that these “typically stop on their own[.]” Of course, whatever their nominal limits, these companies have no way of verifying the baby’s age without an actual examination.
Trump’s DOJ argues, among other things, that pro-life states suffer insufficient harm from FDA rules (despite the effective nullification of their own state protections) to even be able to sue. They’ve also argued that some victims of this regime – women whose boyfriends filled out the form, obtained the pills, and forced the drugs upon them – shouldn’t have standing to sue without proving that it’s likely to happen again. On top of that, they say, the FDA is monitoring the situation, a full review will take place eventually, and that action is unwarranted until the review is finished at some indefinite point in the future.
The best indication we have for the timeline for this review is reporting from last year that Dr. Marty Makary, the head of the FDA, is waiting until after the midterms to decide whether to act. This wouldn’t necessarily be surprising, but it would be enormously ill-advised. According to a recent national polling from <a href="https://sbaprolife.org/wp-content/uploads/2026/02/SBA_National_Memo_Final.pdf">Cygnal</a>, not only do the overwhelming majority of Republicans support returning to the old status quo and restoring in-person visits, but around a third of them would be less likely to vote in the midterms if Republicans weaken their dedication to these and other pro-life policies.
That would be a disaster. In midterms, even small mistakes can lead to large losses, and seriously demoralizing a third of your base would be no small mistake. For our part, we’re planning to spend <a href="https://sbaprolife.org/newsroom/press-releases/leading-pro-life-group-announces-80-million-midterms-investment">$80 million</a> this cycle trying to keep a pro-life majority in the House and Senate. But spurning a third of your base to avoid being on the winning side of a 70-30 issue makes that goal unnecessarily difficult. This may be why nearly every Republican in Congress who is up for re-election has already explicitly asked the administration to change its tune.
In the meantime, each month of inaction means around 10,000 babies like Presley Mae will die – just in the states with the strongest pro-life laws. Abusers will continue to get their hands on these lethal drugs. And countless women and girls will be sent to the emergency room with serious complications.
Pro-life states are right to sue – the FDA, as the administration has already admitted elsewhere, can end this situation immediately if they want to. The harms are real and serious. And failure to act risks not just the midterms, but hundreds of thousands of lives. The fact that Trump’s DOJ is siding with the pro-abortion lobby to get these cases thrown out is a disgrace.
 * * * 
The views expressed in this piece are those of the author and do not necessarily represent those of The Daily Wire.

A Quiet DOJ Move Could Ignite A Midterm Fight

2026 Midterms

When President Trump nominated Robert F. Kennedy, Jr. for HHS Secretary in late 2024, some <a href="https://thehill.com/policy/healthcare/5099888-advancing-american-freedom-opposes-kennedy/">Beltway Republicans</a> tried to tank his nomination. For conservatives, these critics’ strongest argument was that Kennedy was for decades a liberal Democrat who supported abortion on demand.
I’m a pro-life conservative. So why did I, along with millions of others like me, support Kennedy’s nomination and tell skeptical pro-life critics to give him the benefit of the doubt?
For me, the story starts with the COVID lockdowns in 2020. I spent the better part of that year co-authoring <a href="https://www.amazon.com/Price-Panic-Tyranny-Pandemic-Catastrophe/dp/1684511410/ref=sr_1_1">the first book</a> to make the case that locking down the population would do far more harm than good. COVID was the greatest test of wisdom and courage in a generation. Most public officials, from both parties, failed the test. Kennedy aced it.
The raspy-voiced lawyer helped millions of Americans see the dangers of a “biomedical security state” that blurred the binary mental map of free versus communist countries that had served us well during the Cold War. That framework was of limited value for fighting this new, domestic threat to our civil and medical freedom: a corporatist state.
Post-Covid, millions of Americans realized our problem was not just Big Government or Big Business. The problem is, in effect, a cartel that blurs the lines of public and private — one often enabled by a corporate media too dependent on ad revenue to speak truth to the real power.
The lockdowns and draconian vaccine mandates taught another lesson: past partisan ties do not guarantee good future results. For many of us, resisting the COVID-inspired assaults on our liberty was a better credential than party affiliation.
This is one of several reasons millions of conservative voters began to warm to Kennedy, even if they planned to vote for Donald Trump in the general election. And that latent support for Kennedy <a href="https://www.pbs.org/newshour/politics/polls-show-americans-conflicted-on-robert-f-kennedy-jr-and-his-health-stances">exploded</a> after he announced his support for Donald Trump on August 23, 2024.
This was no mere marriage of convenience. It was the first sign of a political realignment. No doubt many staunch progressives <a href="https://www.pewresearch.org/short-reads/2024/08/23/as-rfk-jr-exits-a-look-at-who-supported-him-in-the-2024-presidential-race/">abandoned Kennedy</a> when he endorsed Donald Trump. But many independents and disgruntled Democrats stayed. A new MAGA-MAHA coalition was born.
What made Kennedy’s endorsement of Trump truly historic was the topic he chose to elevate — one of deep concern to tens of millions of American families across the political spectrum but mostly missing from our two major party platforms: the staggering rise of chronic diseases among American children.
As HHS secretary, Kennedy has made the fight against childhood chronic disease his lodestar. And despite constant efforts by critics to paint him as extreme, almost everyone is now taking chronic disease seriously.
But what about the year-old charge that Kennedy would be a cheerleader for abortion? It was wrong. As HHS Secretary, he lacks the power to stop all abortions or close every Planned Parenthood clinic. Kennedy must also work within the constraints of the president who nominated him. But within Kennedy’s remit, his actions have been encouraging.
Last September, for instance, he announced a new FDA review of the safety and approval process of the abortion pill mifepristone. Abortion advocates <a href="https://abcnews.go.com/US/health-secretary-rfk-jr-launches-review-abortion-pill/story?id=125908299">are not pleased</a>. After all, in a Post-Roe world, <a href="https://www.guttmacher.org/2024/03/medication-abortion-accounted-63-all-us-abortions-2023-increase-53-2020">most abortions are chemical</a>, not surgical.
In late January, <a href="https://www.hhs.gov/press-room/conscience-dlc.html">he beefed up federal conscience safeguards</a> for healthcare workers. This protects providers from being forced to participate in abortions or other procedures. This includes new policy guidance and investigations into violations.
Most dramatically, <a href="https://www.hhs.gov/press-room/wtas-hhs-bars-research-using-human-fetal-tissue-from-elective-abortions.html">he has just barred</a> HHS-funded research from using human fetal tissue from elective abortions. Pro-life Americans have asked for this ban for decades. The practice continued even during the tenure of NIH director Francis Collins, an evangelical Christian, who <a href="https://www.politico.com/story/2018/12/18/anti-abortion-groups-francis-collins-nih-1068724">explicitly defended</a> it.
Like Nixon visiting China, I hope Kennedy will do more to defend pre-born human life. It’s not a vain hope. During one telling interview last year, Kennedy denounced a CDC publication that listed “abortion” as one of the top 10 health achievements of the 20th century.
The press “fact-checked” the comment, since <a href="https://www.cdc.gov/mmwr/pdf/wk/mm4812.pdf">the document</a> he likely had in mind listed “family planning” rather than “abortion.” (Pro-life advocates recognize the family planning as a euphemism for abortion.) But most missed the crucial “tell”: Kennedy recoiled from the notion that abortion could be cited as a health care achievement.
For pro-life conservatives, supporting Kennedy’s nomination posed some risk. One year in, however, my choice to support Robert F. Kennedy, Jr. is an easy one.
* * *
Jay W. Richards, PhD, is Vice President for Social and Domestic Policy at The Heritage Foundation.
The views expressed in this piece are those of the author and do not necessarily represent those of The Daily Wire.

Menu

FDA